摘要
目的研究在多发性硬化的药物中,干扰素β-1b的治疗效果。方法根据我院2014年11月～2015年11月收治的多发性硬化患者70例的临床资料,将其随机分成A组与B组,每组各35例患者,为B组中的病患提供地塞米松,A组中的病患在此基础上加入干扰素β-1b,对比两组患者治疗前后神经功能缺损情况、生活活动量评分、复发率等。结果两组患者治疗前以上指标对比,差异均无统计学意义,P>0.05;相较于治疗前,经过治疗两组患者的神经功能缺损情况、生活活动量评分、复发率均得到有效提升,且A组改善程度优于B组,P<0.05,差异有统计学意义。结论在多发性硬化的药物治疗中,干扰素β-1b能够有效提高患者的神经功能,优化患者的生活质量,减少复发率。
Objective To study the curative effect of Interferon beta-1b in drug for multiple sclerosis.Methods From November 2014 to November 2015, 70 cases of patients with multiple sclerosis in our hospital were randomly divided into group A and group B, 35 cases of patients in each group. Group B was treated with dexamethasone, group A was treated with interferon beta-1b, to compare the situation of nerve function defect, the score of life activity and the recurrence rate about two groups of patients before and after treatment.ResultsThere were no statistically signiifcant difference about the above indexes between two groups of patients before treatment,P〉0.05. Compared with before treatment, the situation of nerve function defect, the score of life activity and the recurrence rate of two groups of patients after treatment are effectively promoted, and the degree of improvement of group A is better than that of group B, the difference was statistically significant （P〈0.05）.Conclusion In the drug treatment of multiple sclerosis, interferon beta 1-b can effectively improve the patient＆#39;s nerve function, optimize the life quality of patients and reduce the recurrence rate.
出处
《中国继续医学教育》
2016年第11期171-172,共2页
China Continuing Medical Education
关键词
多发性硬化
治疗效果
Multiple sclerosis
Interferon beta 1-b
The curative effect
